Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Febuxostat - Important Safety Information from Marketing Authorisation Holders of products containing febuxostat as approved by HPRA
Notice type:
3rd Party Publications
Date:
28/06/2019
Problem Or Issue:
Important Safety Information communication from Marketing Authorisation Holders of products containing Febuxostat: increased risk of cardiovascular death and all-cause mortality in patients treated with febuxostat in the CARES study
Important Safety Information - Febuxostat
« Back
Date Printed: 25/04/2024